Study Title: Extension of lifespan by epicatechin, halofuginone and mitoglitazone in male but not female genetically heterogeneous mice
Citation: Strong et al., 2025, Springer Nature.
Tags:
Mitozz, (−)-epicatechin, healthy aging, longevity
What the Study Found:
This controlled animal study tested dietary epicatechin in genetically diverse male and female mice at three research sites.
Male mice receiving epicatechin had a modest increase in median lifespan. Female mice did not show a significant lifespan benefit.
The study did not directly measure mitochondrial function, ATP production, or the biological reason for the male-specific result.
Clinical Relevance:
This was a mouse study, not a human clinical trial. It does not show that epicatechin, cocoa flavanols, dark chocolate, or Mitozz extends human lifespan.
What this means in real life:
The finding adds to preclinical research on epicatechin and aging biology. However, it is not evidence that people will experience the same effect.
More human research is needed to understand dose, safety, mechanisms, and whether any lifespan-related effects translate beyond animal models.
Related Content:
- Want to understand epicatechin and mitochondrial research? → Mitozz, (-)-Epicatechin and “Mitochondrial Support”
- Want to explore the broader science? → (-)-Epicatechin and Mitochondrial Health: What the Science Suggests
- Want to learn about practical mitochondrial-health foundations? → How to Repair and Maintain Mitochondrial Health Naturally